As one of the industries closely related to the health of the people, the standard of living, and the development of science and technology, the pharmaceutical industry has a good development prospect and is an important part of the national economy of our country. Since the reform and opening up, China's pharmaceutical industry has maintained a rapid growth trend. According to the statistics published by the national health and Family Planning Commission "2013 China Health Statistics Yearbook", the total cost of medical and health expenditure in China has reached 2 trillion and 784 billion 580 million yuan in 2012, accounting for 5.36% of the proportion of GDP in that year. In 2012 1-12, the output value of pharmaceutical industry was 18770 billion yuan, an increase of 20.10% over the same period last year. According to the data of "the blue book of China's pharmaceutical market development in 2014" by the CFDA Southern Pharmaceutical Institute of medicine and economics, the total output value of China's pharmaceutical industry has maintained a sustained and rapid growth trend. The total output value of China's pharmaceutical industry rose from 671 billion 900 million yuan in 2007 to 22297 billion yuan in 2013, with an annual average growth rate of 22.13%. According to the relevant data of the National Bureau of statistics, the main business income of Pharmaceutical Enterprises above Designated Size reached 2013 billion yuan in 21681.6, an increase of 17.9% over the same period last year.
Source: CFDA Blue Book of China pharmaceutical market, 2014, Southern Institute of medical economics
Although China's pharmaceutical industry has developed rapidly, it is affected by the lower level of per capita income and medical security in our country, and there is still a big gap in the scale of China's pharmaceutical market compared with the developed countries at this stage. Compared with the level of medical expenditure in the middle and high income countries, China's per capita medical expenditure is only a few dozen of them, and the gap is very large. The lower level of consumption indicates great potential for market growth.
In general, China's pharmaceutical industry will continue to maintain a rapid growth rate. The "12th Five-Year" development plan issued by the Ministry of industry and information in 2011 is expected to maintain the average annual growth rate of 20%, the annual growth of industrial value added by 16%, and the total industrial output value of 3 trillion in 2015, and more than 3 trillion of the total industrial output value in 2015. Yuan. At present, China has become the world's third largest pharmaceutical market in the world. It is estimated that 2015 will be the number one in the world in.